Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07072377 · ClinicalTrials.gov registry record · NA

Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)

A NA study of Malnutrition and Rural Health, sponsored by University of Vermont Medical Center.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT07072377: Recruiting NA study of Malnutrition and Rural Health, sponsored by University of Vermont Medical Center.

NCT07072377 is a NA study of Malnutrition and Rural Health that is actively recruiting participants, run by University of Vermont Medical Center. The registered enrollment target is 240 participants, below the 375-participant average among 17 other Malnutrition trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07072377, a NA study of Malnutrition and Rural Health, is actively recruiting participants, sponsored by University of Vermont Medical Center.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

Brief Summary The goal of this clinical trial is to evaluate the acceptability and adherence of low- and high-intensity remote nutritional interventions for cancer patients in rural and urban areas, specifically focusing on those with invasive cancer who are about to start treatment. The main question\[s\] it aims to answer are: Can low- and high-intensity remote nutritional interventions improve adherence to cancer treatment and quality of life? What is the impact of nutritional support on treatment delays, unplanned healthcare utilization, and dietary modifications? Researchers will compare the low-intensity arm (initial nutritional consultation plus written materials) to the high-intensity arm (1-hour consultation, monthly follow-ups, and written materials) to see if higher intensity interventions lead to better outcomes in terms of adherence, quality of life, and healthcare utilization. Participants will: Receive either a low- or high-intensity nutritional consultation. Complete surveys assessing quality of life, dietary habits, treatment delays, and unplanned healthcare use. Be asked to participate in monthly follow-up consultations (for the high-intensity group) to track progress and provide additional support.

Primary Outcome

Adherence will be assessed over the 6-week intervention period using two metrics: 1. Proportion of scheduled dietary counseling contacts completed (≥70% completion threshold), and 2. Participant self-report of meeting ≥70% of individualized nutrition goals, recorded weekly. Adherence will be summarized as the percentage of participants in each arm who meet both criteria. Unit of Measure: Percentage of participants meeting adherence threshold (%)

Interventions

  • BEHAVIORAL Intensity of Nutritional Intervention
  • BEHAVIORAL Remote or In-Person

Study Locations (1)

Vermont

  • University of Vermont Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2025-09-10
Est. Completion 2028-09
Phase NA

What NCT07072377 shows while recruiting

NCT07072377 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 375-participant average among 17 other Malnutrition trials with a reported enrollment target (36% lower).

The record links to 6 conditions, with Malnutrition appearing as the primary indexed condition, and to 2 interventions - of which Intensity of Nutritional Intervention is the first listed.

NCT07072377 reports a single indexed study location in Vermont.

Frequently Asked Questions

What is clinical trial NCT07072377 about?

NCT07072377 is a clinical study titled "Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)". Brief Summary The goal of this clinical trial is to evaluate the acceptability and adherence of low- and high-intensity remote nutritional interventions for cancer patients in rural and urban areas, specifically focusing on those with invasive cancer who are about to start treatment. The main quest...

What is the current status of trial NCT07072377?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-09-10. Estimated completion is 2028-09.

What conditions does trial NCT07072377 study?

This clinical trial studies the following conditions: Malnutrition, Rural Health, Quality of Life (QOL), Cancer-related Malnutrition, Nutritional Support.

What interventions are being tested in trial NCT07072377?

The interventions under investigation include: Intensity of Nutritional Intervention (BEHAVIORAL), Remote or In-Person (BEHAVIORAL).

Who is sponsoring clinical trial NCT07072377?

This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07072377 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malnutrition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07072377's enrollment target sits among peer trials

240 6th of 17 higher than 12 of 17 other Malnutrition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malnutrition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07072377, the US trial registry maintained by the National Library of Medicine. NCT07072377 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.